Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: Data from a multicenter study

BMJ Open

Volumn 3, Issue 12, 2013, Pages

  Qiao, Lu Dong ^a   Chen, Shan ^a   Yang, Yong ^b   Zhang, Kai ^c   Zheng, Bo ^c   Guo, Hong Feng ^d   Yang, Bo ^e   Niu, Yuan Jie ^f   Wang, Yi ^g   Shi, Ben Kang ^h   Yang, Wei Min ⁱ   Zhao, Xiao Kun ^j   Gao, Xiao Feng ^k   Chen, Ming ^l   Tian, Ye ^m  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

^d PEKING UNIVERSITY SHOUGANG HOSPITAL   (China)

^e PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^f TIANJIN MEDICAL UNIVERSITY   (China)

^g CHINA MEDICAL UNIVERSITY   (China)

^h SHANDONG UNIVERSITY   (China)

ⁱ Tongji Hospital   (China)

^j CENTRAL SOUTH UNIVERSITY   (China)

^k SECOND MILITARY MEDICAL UNIVERSITY   (China)

^l SOUTHEAST UNIVERSITY   (China)

^m CAPITAL MEDICAL UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFDINIR; CEFIXIME; CEFOTAXIME; CEFPROZIL; CEFTAZIDIME; CEFUROXIME; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN TROMETAMOL; LEVOFLOXACIN; MOXIFLOXACIN; NITROFURANTOIN; OXACILLIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BROTH DILUTION; CHINA; CYSTITIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PATHOGENESIS; RECURRENT INFECTION; STAPHYLOCOCCUS EPIDERMIDIS; URINALYSIS; URINARY TRACT INFECTION;

EID: 84890540572     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004152     Document Type: Article

References (30)

1. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis 2001;183(Suppl 1):S1-4.
2. Foxman B, Barlow R, d'Arcy H, et al. Urinary tract infection: estimated incidence and associated costs. Ann Epidemiol 2000;10:509-15.
3. Carlson KJ, Mulley AG. Management of acute dysuria: a decision analysis model of alternative strategies. Ann Intern Med 1985;102:244-9.
4. Kunin CM. Urinary tract infections in females. Clin Infect Dis 1994;18:1-10.
5. Engel JD, Schaeffer AJ. Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women. Urol Clin North Am 1998;25:685-701.
6. Foxman B, Gillespie B, Koopman J, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol 2000;151:1194-205.
7. Foxman B, Frerichs RR. Epidemiology of urinary tract infection. II. Diet, clothing, and urination habits. Am J Public Health 1985;75:1314-17.
8. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity and economic costs. Am J Med 2002;113(Suppl 1A):5S-13S.
9. Jiangqiao W, Xueping W, Yujuan L. Nosocomial infection point-prevalence survey in three consecutive years. Chin J Infect Control 2006;5:19-34.
10. Jinxian W, Xiaoling Z, Liya Y. A nosocomial infection point-prevalence survey: results and analysis. Chinese J Nosocomiol 2005;15:1119-20.
11. Talan D, Stamm W, Hooton T, et al. Comparison of ciprofloxacin (7days) and trimethoprim-sulfamethoxazole (14days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000;283:1583-90.
12. Qi HM, Lv Y, Qian X. Ministry of Health National Antimicrobial Resistant Investigation Net 2010 annual report: bacterial resistances monitor of women urine samples. Chinese J Clin Pharmacol 2011;27:913-18.
13. Zheng B, Lv Y. Ministry of Health National Antimicrobial Investigation Net 2010 report: bacterial distribution and resistance in urinary tract infections in male. Chinese J Clin Pharmacol 2011;27:905-12.
14. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI document M100-S20. Wayne: CLSI, 2011.
15. Sanders CC, Barry AL, Washington JA, et al. Detection of extended spectrum beta-lactamases producing members of family Enterobacteriaceae with the Vitek ESBL test. J Clin Microbiol 1996;34:2997-3001.
16. Lei G, Yonghong X. 2006-2007 Mohnarin report:Bacterial distribution and resistance in urinary tract infections. Chinese J Antibiotics 2008;33:586-634.
17. Khan AU, Zaman MS. Multiple drug resistance pattern in Urinary Tract Infection patients in Aligarh. Biomed Res 2006;17:179-81.
18. Mishra MP, Debata NK, Padhy RN, et al. Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in Indian. Asian Pac J Trop Biomed 2013;3:315-24.
19. Mukherjee M, Basu S, Mukherjee SK, et al. Multidrug-resistance and extended spectrum beta-lactamase production in uropathogenic E. Coli which were isolated from hospitalized patients in Kolkata, India. J Clin Diagn Res 2013;7:449-53.
20. Odongo CO, Anywar DA, Luryamamoi K, et al. Antibiograms from community-acquired uropathogens in Gulu, northern Uganda-a cross-sectional study. BMC Infect Dis 2013;13:193.
21. Guangying Y, Xueyin Z, Anrong L. Development of a novel test identifying extended-spectrum beta lactamase producing strains relative to resistant plasmids. Chin J Microecol 2002; 14:89-90.
22. Hua Y, Hua L, Yingjun Y. Distribution of pathogens and resistance detection in urinary infection. Chinese J Nosocomiol 2003;13:982-4.
23. Haishen K, Baoguan W, Yi G. Drug resistance of Pneumonia klebsiella and E. coli to ultra wide spectrum Beta-lactam enzyme. Chinese J LabMed 2000;1:23-5.
24. Maraki S, Samonis G, Rafailidis PI, et al. Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob Agents Chemother 2009;53:4508-10.
25. Piette A, Verschraegen G. Role of coagulase-negative staphylococci in human disease. Vet Microbiol 2009;134:45-54.
26. Huebner J, Goldmann DA. Coagulase-negative staphylococci: role as pathogens. Annu Rev Med 1999;50:223-36.
27. O'Gara JP, Humphreys H. Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol 2001;50:582-7.
28. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-22.
29. Mack D, Davies AP, Harris LG, et al. Microbial interactions in Staphylococcus epidermidis biofilms. Anal Bioanal Chem 2001;387:399-408.
30. Perri MB, Hershberger E, Ionescu M, et al. In vitro susceptibility of vancomycin-resistant Enterococci (VRE) to fosfomycin. Diagn Microbiol Infect Dis 2002;42:269-71a.